Displaying 2281 - 2300 of 2528
Announced Actions for September 16, 1999
Workshop: Market Power and Consumer Protection Issues Involved with Encouraging Competition in the U.S. Electric Industry
FTC Releases Report on Commission's Divestiture Process
Antitrust and Intellectual Property Law: From Adversaries to Partners
Antitrust in a Global High-Tech Economy
Monier Lifetile Will Sell Assets to Settle FTC Antitrust Charges
21st Report (FY 1998)
Mylan, Nation's Second Largest Generic Drug Maker, Charged with Restraint of Trade, Conspiracy & Monopolization
Proposed Consent Order Would Bar Restraints on Competition For Marine Pilot Services in Oregon
Licensing and Antitrust: Common Goals and Uncommon Problems
FTC Charges Lafarge, Boral Violated Antitrust Laws
Auto Dealers in Northwest Threatened Chrysler with Illegal Boycott; FTC Settles Charges
Competition and Consumer Protection Issues in the Digital Economy
20th Report (FY 1997)
CVS Corporation, and Revco D.S., Inc.
CVS agreed to settle allegations that its acquisition of Revco would substantially reduce competition for the retail sale of pharmacy services to health insurance companies and other third-party payers in Virginia and in the Binghamton, New York metropolitan area. The consent order requires the divestiture of 114 Revco stores in Virginia and 6 pharmacy counters in Binghamton.
In March, 1998, CVS Corporation agreed to pay a $600,000 civil penalty to settle Federal Trade Commission charges that the company violated a 1997 consent order and asset maintenance agreement it signed with the agency to settle charges stemming from CVS's 1997 acquisition of Revco D.S., Inc.
Displaying 2281 - 2300 of 2528